We followed that discovery by meticulously mapping the multiple mechanisms by which increasing cAMP levels, a direct consequence of PDE4 inhibition, suppress lymphoma cell growth and modulate the tumor microenvironment [11,12,13,16,17]. The gene discussed is PDE4A; the disease is lymphoma.